Skip to main content

Dr. Kulkarni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kulkarni's full profile

Already have an account?

Education & Training

  • Children's Hospital of Michigan
    Children's Hospital of MichiganResidency, Pediatrics, 1974 - 1975
  • Children's Hospital of Michigan
    Children's Hospital of MichiganFellowship, Pediatric Hematology/Oncology, 1972 - 1975
  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 1973 - 1974
  • Children's Hospital of Michigan
    Children's Hospital of MichiganResidency, Pediatrics, 1971 - 1973
  • HCA HealthONE /Presbyterian-St Luke’s Medical Center
    HCA HealthONE /Presbyterian-St Luke’s Medical CenterInternship, Transitional Year, 1969 - 1970
  • Osmania Medical College NTR UHS
    Osmania Medical College NTR UHSClass of 1968

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1978 - Present
  • MI State Medical License
    MI State Medical License 1973 - 2025
  • GA State Medical License
    GA State Medical License 2006 - 2008
  • CO State Medical License
    CO State Medical License 1977 - 1978
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial
    Roshni Kulkarni, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/7/2019

Press Mentions

  • Hemophilia and Telehealth: Navigating the Virtual Clinic
    Hemophilia and Telehealth: Navigating the Virtual ClinicDecember 22nd, 2020
  • Highlights from the First-Ever WFH Global Summit on WGBDs
    Highlights from the First-Ever WFH Global Summit on WGBDsDecember 8th, 2020
  • Long-Term Safety and Efficacy Data of Extended Half-Life Therapy ALPROLIX® in Children with Hemophilia B Published in the Lancet Haematology
    Long-Term Safety and Efficacy Data of Extended Half-Life Therapy ALPROLIX® in Children with Hemophilia B Published in the Lancet HaematologyFebruary 8th, 2017

Hospital Affiliations